CompaniesBeyondSpring Pharmaceuticals
BeyondSpring Pharmaceuticals logo

BeyondSpring Pharmaceuticals

active
Florham Park, NJ, United States
Founded 2013
Website
About

Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalNJ, NY, PA
Team (6)
Brendan Delaney
Brendan Delaney
BeyondSpring Pharmaceuticals
team_member
LAN HUANG, Ph.D.
LAN HUANG, Ph.D.
BeyondSpring Pharmaceuticals
team_member
Lan Huang, Ph.D.
Lan Huang, Ph.D.
BeyondSpring Pharmaceuticals
team_member
Matthew Kirkby
Matthew Kirkby
BeyondSpring Pharmaceuticals
team_member
Patrick Fabbio
BeyondSpring Pharmaceuticals
team_member
Ramon Mohanlal, M.D., Ph.D.
Ramon Mohanlal, M.D., Ph.D.
BeyondSpring Pharmaceuticals
team_member
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

5

As Collaborator

4

Total Enrollment

1,176

By Phase

PHASE2: 4PHASE3: 3PHASE1/PHASE2: 1PHASE1: 1

By Status

COMPLETED: 5ACTIVE_NOT_RECRUITING: 3UNKNOWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT02504489
NCT02812667
NCT03102606
NCT03575793
NCT03294577
NCT05130827
NCT05599789
Hover over trial bars to see details

Recent Trials

NCT05599789Collaborator
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)
PHASE2Active, not recruiting
47 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
NCT05130827Collaborator
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
NCT03294577Lead Sponsor
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
PHASE3Unknown
221 participants
Started: Oct 23, 2019 · Completed: Sep 25, 2025
NCT03575793Collaborator
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
PHASE1/PHASE2Completed
39 participants
Started: Sep 6, 2018 · Completed: Jul 1, 2024
NCT03102606Lead Sponsor
Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3
PHASE3Completed
105 participants
Started: May 29, 2018 · Completed: Feb 8, 2021
View all 9 trials →
Locations (1)
Headquarters
Florham Park, NJ, United States
Map

Loading map...